energy + chips
Today’s Change (Sep 9, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
A small, risk-based mix of leveraged sector funds (energy, healthcare/biotech) plus cash. It gives more weight to the calmer choices over the last year. No scheduled rebalancing. Very aggressive funds are tempered by potentially large cash weight.
It holds five items: CURE (3x healthcare), ERX (2x energy), LABU (3x biotech), SHNY (a lesser‑known ETF; please confirm its focus), and USD cash.
It looks at about the last 1 year of price swings; calmer funds get bigger slices and jumpier ones get smaller. Cash can take a large slice because it barely moves.
No automatic rebalancing. Despite the name, there’s no semiconductor ETF here.
Out-of-sample edge: Sharpe 3.60 vs SPY 1.22, Calmar 31.3, and far higher annualized gains, driven by a volatility-aware tilt to calmer assets and cash. Stronger risk-adjusted upside than the S&P 500, with hedged drawdowns.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
| Alpha | Beta | R2 | R | |
|---|---|---|---|---|
| 0.24 | 1.68 | 0.51 | 0.71 |
Performance Metrics
| Cumulative Return | Annualized Return | Trailing 1M Return | Trailing 3M Return | Sharpe Ratio | |
|---|---|---|---|---|---|
| 58.7% | 19.98% | -0.91% | 3.88% | 1.23 | |
| 254.87% | 64.79% | 3.27% | 29.36% | 1.53 |
Initial Investment
$10,000.00
Final Value
$35,486.78Regulatory Fees
$0.47
Total Slippage
$3.63
Invest in this strategy
OOS Start Date
Jul 15, 2026
Trading Setting
Threshold 15%
Type
Stocks
Category
Leveraged sector etfs, inverse-volatility weighting, energy, healthcare/biotech, cash, 250-day lookback, tactical allocation, no auto rebalance